1 Report Introduction

2 Executive Summary of Microscopic Polyangiitis (MPA)

3 Disease Background and Overview
3.1 Introduction
3.2 Causes
3.3 Symptoms of MPA
3.4 Clinical Manifestations of MPA
3.5 Pathogenesis of MPA
3.6 Biomarkers of MPA
3.7 Genetic Analysis
3.8 Diagnosis of MPA
3.8.1 Diagnostic Algorithm of Vasculitis
3.8.2 Diagnostic Guidelines of MPA
3.8.2.1 Revised 2017 International Consensus on Testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
3.8.2.2 EULAR/ERA-EDTA Recommendations for the Management of ANCA-associated Vasculitis
3.8.2.3 SICVE guidelines: Systemic vasculitis

4 Epidemiology and Patient Population
4.1 Key Findings
4.2 Methodology of Epidemiology
4.3 Total Incident Cases of Microscopic polyangiitis (MPA) in the 7MM
4.4 Epidemiology of Microscopic polyangiitis (MPA)
4.5 The United States
4.5.1 Total Incident Cases of Microscopic polyangiitis (MPA) in the US
4.5.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in the US
4.5.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in the US
4.6 EU5
4.6.1 Germany
4.6.1.1 Total Incident Cases of Microscopic polyangiitis (MPA) in Germany
4.6.1.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Germany
4.6.1.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Germany
4.6.2 France
4.6.2.1 Total Incident Cases of Microscopic polyangiitis (MPA) in France
4.6.2.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in France
4.6.2.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in France
4.6.3 Italy
4.6.3.1 Total Incident Cases of Microscopic polyangiitis (MPA) in Italy
4.6.3.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Italy
4.6.3.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Italy
4.6.4 Spain
4.6.4.1 Total Incident Cases of Microscopic polyangiitis (MPA) in Spain
4.6.4.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Spain
4.6.4.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Spain
4.6.5 The United Kingdom
4.6.5.1 Total Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom
4.6.5.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom
4.6.5.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom
4.7 Japan
4.7.1 Total Incident Cases of Microscopic polyangiitis (MPA) in Japan
4.7.2 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Japan
4.7.3 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Japan

5 Patient Journey

6 Appendix
6.1 Report Methodology

7 DelveInsight Capabilities

8 Disclaimer

9 About DelveInsight

List of Tables
Table 1 Summary of MPA, Epidemiology and Key Events (2018-2030)
Table 2 Summary of biomarkers/potential biomarkers in AAV
Table 3 SICVE guidelines: Systemic vasculitis Recommendations
Table 4 Total Incident Cases of Microscopic polyangiitis (MPA) in the 7MM (2018-2030)
Table 5 Total Incident Cases of Microscopic polyangiitis (MPA) in the United States (2018-2030)
Table 6 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in the United States (2018-2030)
Table 7 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in the United States (2018-2030)
Table 8 Total Incident Cases of Microscopic polyangiitis (MPA) in Germany (2018-2030)
Table 9 Total Incident Cases of Microscopic polyangiitis (MPA) in Germany (2018-2030)
Table 10 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Germany (2018-2030)
Table 11 Total Incident Cases of Microscopic polyangiitis (MPA) in France (2018-2030)
Table 12 Gender-specific Total Incident Cases of Microscopic polyangiitis (MPA) in France (2018-2030)
Table 13 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in France (2018-2030)
Table 14 Total Incident Cases of Microscopic polyangiitis (MPA) in Italy (2018-2030)
Table 15 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Italy (2018-2030)
Table 16 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Italy (2018-2030)
Table 17 Total Incident Cases of Microscopic polyangiitis (MPA) in Spain (2018-2030)
Table 18 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Spain (2018-2030)
Table 19 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Spain (2018-2030)
Table 20 Total Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom (2018-2030)
Table 21 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom (2018-2030)
Table 22 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom (2018-2030)
Table 23 Total Incident Cases of Microscopic polyangiitis (MPA) in Japan (2018-2030)
Table 24 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Japan (2018-2030)
Table 25 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Japan (2018-2030)

List of Figures
Figure 1 Vasculitis
Figure 2 Microscopic polyangiitis (MPA)
Figure 3 Symptoms of Microscopic polyangiitis (MPA)
Figure 4 Five most common clinical manifestations of MPA
Figure 5 Pathogenesis of MPA
Figure 6 Diagnostic Algorithm for Vasculitis
Figure 7 Diagnostic algorithm of MPA
Figure 8 Total Incident Cases of Microscopic polyangiitis (MPA) in the 7MM (2018-2030)
Figure 9 Total Incident Cases of Microscopic polyangiitis (MPA) in the United States (2018-2030)
Figure 10 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in the United States (2018-2030)
Figure 11 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in the United States (2018-2030)
Figure 11 Total Incident Cases of Microscopic polyangiitis (MPA) in Germany (2018-2030)
Figure 13 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Germany (2018-2030)
Figure 14 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Germany (2018-2030)
Figure 15 Total Incident Cases of Microscopic polyangiitis (MPA) in France (2018-2030)
Figure 16 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in France (2018-2030)
Figure 17 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in France (2018-2030)
Figure 18 Total Incident Cases of Microscopic polyangiitis (MPA) in Italy (2018-2030)
Figure 19 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Italy (2018-2030)
Figure 20 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Italy (2018-2030)
Figure 21 Total Incident Cases of Microscopic polyangiitis (MPA) in Spain (2018-2030)
Figure 22 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Spain (2018-2030)
Figure 23 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Spain (2018-2030)
Figure 24 Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom (2018-2030)
Figure 25 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom (2018-2030)
Figure 25 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in the United Kingdom (2018-2030)
Figure 27 Total Incident Cases of Microscopic polyangiitis (MPA) in Japan (2018-2030)
Figure 28 Gender-specific Incident Cases of Microscopic polyangiitis (MPA) in Japan (2018-2030)
Figure 29 Age-specific Incident Cases of Microscopic polyangiitis (MPA) in Japan (2018-2030)